Christopher Lee, MD
Advertisement
Articles by Christopher Lee, MD
Advertisement
Latest Updated Articles
Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancerPublished: October 2nd 2025 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
Beyond the clinic: Physician presence on social media
2
FDA updates in urology: December 2025
3
Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions
4
Study validates Decipher as a predictor of early biochemical recurrence in prostate cancer
5